NEW YORK, Dec. 18 (GenomeWeb News) - Tranzyme has acquired Québec-based Neokimia, the companies said today.
Financial details were not disclosed. However, Vipin Garg, president and CEO of Tranzyme, said both companies were valued at around $7.5 million at the time of the deal.
Already have a GenomeWeb or 360Dx account?Login Now.
The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.
A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.
Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.
In Science this week: analysis of DNA from ancient North Africans, and more.